Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woerle, H. J.
Right arrow Articles by Gerich, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woerle, H. J.
Right arrow Articles by Gerich, J. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1386-1392, 2003
© 2003 by the American Diabetes Association, Inc.

Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes

Further Evidence for Hepatorenal Reciprocity

Hans J. Woerle1, Christian Meyer1, Emilia M. Popa1, Philip E. Cryer2, and John E. Gerich1

1 Department of Medicine, University of Rochester School of Medicine, Rochester, New York
2 Department of Endocrinology, Diabetes and Metabolism, Washington University School of Medicine, St. Louis, Missouri

During liver transplantation and after both meal ingestion and prolonged fasting, renal glucose release (RGR) increases while hepatic glucose release (HGR) decreases. These and other observations have led to the concept of hepatorenal reciprocity. According to this concept, reciprocal changes in hepatic and renal glucose release may occur to minimize deviations from normal glucose homeostasis. We further assessed this concept by testing the hypothesis that during counterregulation of hypoglycemia in patients with type 2 diabetes, who would be expected to have reduced HGR, RGR would be increased. Accordingly, we performed hypoglycemic hyperinsulinemic clamp experiments (~3.1 mmol/l) in 12 type 2 diabetic and in 10 age-weight-matched nondiabetic volunteers and measured total endogenous glucose release (TEGR) and RGR using a combined isotopic net balance approach. HGR was calculated as the difference between TEGR and RGR since only these organs are capable of releasing glucose. We found that during comparable hypoglycemia and hyperinsulinemia, TEGR was reduced in type 2 diabetes (6.6 ± 0.6 vs. 10.2 ± 1.1 µmol · kg-1 · min-1 in nondiabetic volunteers, P = 0.01) due to reduced HGR (3.9 ± 0.5 vs. 8.6 ± 1.0 µmol · kg-1 · min-1 in nondiabetic volunteers, P = 0.0015). In contrast, RGR was increased approximately twofold in type 2 diabetes (3.3 ± 0.5 vs. 1.6 ± 0.3 µmol · kg-1 · min-1 in nondiabetic volunteers, P = 0.015). Plasma epinephrine, lactate, and free fatty acid concentrations, which would promote RGR, were also greater in type 2 diabetes (all P < 0.01). Our results provide further support for hepatorenal reciprocity and may explain at least in part the relatively low occurrence of severe hypoglycemia in type 2 diabetes compared with type 1 diabetes where both HGR and RGR counterregulatory responses are reduced.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
B. E. Dunning and J. E. Gerich
The Role of {alpha}-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications
Endocr. Rev., May 1, 2007; 28(3): 253 - 283.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. N. Zammitt and B. M. Frier
Hypoglycemia in Type 2 Diabetes: Pathophysiology, frequency, and effects of different treatment modalities
Diabetes Care, December 1, 2005; 28(12): 2948 - 2961.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Battezzati, A. Caumo, F. Martino, L. P. Sereni, J. Coppa, R. Romito, M. Ammatuna, E. Regalia, D. E. Matthews, V. Mazzaferro, et al.
Nonhepatic glucose production in humans
Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E129 - E135.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.